Use and duration of chemotherapy (CT) in patients (pts) with metastatic breast cancer (MBC) according to tumor subtype (TS) and line of therapy (tx).
Davinia Shien Seah
No relevant relationships to disclose
Ines Maria Vaz Duarte Luis
No relevant relationships to disclose
Erin Macrae Olson
No relevant relationships to disclose
Jessica Sohl
No relevant relationships to disclose
Georgia Litsas
No relevant relationships to disclose
Eric Winer
Research Funding - Genentech
Nancy U. Lin
Consultant or Advisory Role - Genentech (U); GlaxoSmithKline; Novartis
Research Funding - Boehringer Ingelheim; Genentech; GlaxoSmithKline; Infinity
Harold J. Burstein
No relevant relationships to disclose